Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
AMPK activation protects against prostate cancer by inducing a catabolic cellular state.
Cell Rep. 2023 Apr 25;42(4):112396. doi: 10.1016/j.celrep.2023.112396. Epub 2023 Apr 15.
Cell Rep. 2023.
PMID: 37061917
Free PMC article.
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.
Fletcher CE, Deng L, Orafidiya F, Yuan W, Lorentzen MPGS, Cyran OW, Varela-Carver A, Constantin TA, Leach DA, Dobbs FM, Figueiredo I, Gurel B, Parkes E, Bogdan D, Pereira RR, Zhao SG, Neeb A, Issa F, Hester J, Kudo H, Liu Y, Philippou Y, Bristow R, Knudsen K, Bryant RJ, Feng FY, Reed SH, Mills IG, de Bono J, Bevan CL.
Fletcher CE, et al. Among authors: constantin ta.
Mol Cancer. 2022 Mar 22;21(1):82. doi: 10.1186/s12943-022-01540-w.
Mol Cancer. 2022.
PMID: 35317841
Free PMC article.
Item in Clipboard
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer.
Constantin TA, Greenland KK, Varela-Carver A, Bevan CL.
Constantin TA, et al.
Oncogene. 2022 Jun;41(24):3303-3315. doi: 10.1038/s41388-022-02347-1. Epub 2022 May 14.
Oncogene. 2022.
PMID: 35568739
Free PMC article.
Review.
Item in Clipboard
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai CF, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL.
Constantin TA, et al.
Br J Cancer. 2023 Jun;128(12):2326-2337. doi: 10.1038/s41416-023-02252-8. Epub 2023 Apr 19.
Br J Cancer. 2023.
PMID: 37076563
Free PMC article.
Item in Clipboard
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai CF, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL.
Constantin TA, et al.
Br J Cancer. 2024 Mar;130(5):892. doi: 10.1038/s41416-024-02606-w.
Br J Cancer. 2024.
PMID: 38355841
Free PMC article.
No abstract available.
Item in Clipboard
A cell-cycle signature classifier for pan-cancer analysis.
Tabassum N, Constantin TA, Cereser B, Stebbing J.
Tabassum N, et al. Among authors: constantin ta.
Oncogene. 2020 Sep;39(38):6041-6042. doi: 10.1038/s41388-020-01426-5. Epub 2020 Aug 20.
Oncogene. 2020.
PMID: 32820254
No abstract available.
Item in Clipboard
Correction to: A cell-cycle signature classifier for pan-cancer analysis.
Tabassum N, Constantin TA, Cereser B, Stebbing J.
Tabassum N, et al. Among authors: constantin ta.
Oncogene. 2021 Mar;40(9):1752. doi: 10.1038/s41388-021-01649-0.
Oncogene. 2021.
PMID: 33510356
No abstract available.
Item in Clipboard
Cite
Cite